Información del artículo
El Texto completo está disponible en PDF
References
[1.]
H. Kindmark, A. Sundin, D. Grandberg, K. Dunden, B. Skogseid, E.T. Janson, et al.
Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
Med Oncol, 24 (2007), pp. 330-337
[2.]
A.P. Van Beek, E.R.M. de Haas, W.A. van Vloten, C.J.M. Lips, J.F.M. Roijers, M.R. Canninga-van Dijk.
The glucogonoma syndrome and necrolytic migratory erythema: a clinical review.
Eur J Endocrinol, 151 (2004), pp. 531-537
[3.]
R.A. Wermers, V. Fatourechi, A.G. Wynne, L.K. Kvols, R.V. Lloyd.
The glucagonoma syndrome: clinical and pathology features in 21 patients.
Medicine, 75 (1996), pp. 53-63
[4.]
M. Echenique-Elizondo, A. Tuneu, J.L. Elorza, I. Martínez de Lizardury, J. Ibáñez.
Síndrome del glucagonoma y seudoglucagonoma.
Cir Esp, 76 (2004), pp. 318-324
[5.]
R. Pujol, C.E. Wang, R.A. el-Azhary, W.P.D. Su, L.E. Gibson, A.L. Schroeter.
Necrolytic migratory erythema: clinicopathologic study of 13 cases.
Int J Dermatol, 43 (2004), pp. 12-18
[6.]
E. Vauleon, J. Egreteau, E. Boucher, V. Desfourneaux, J.F. Bretagne, J.L. Raoul.
Glucagonoma: a recent series of 7 cases.
Bull Cancer, 91 (2004), pp. 637-640
[7.]
A.I. Vinik, E.A. Woltering, R.P.P. Warner, M. Caplin, T.M. O’Dorisio, G.A. Wiseman, et al.
NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor.
Pancreas, 39 (2010), pp. 713-734
[8.]
A. Rinke, H.H. Müller, C. Schade-Brittinger, K.J. Klose, P. Barth, M. Wied, et al.
PROMID Study Group. Placebo-controlled, doubleblind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
J Clin Oncol, 27 (2009), pp. 4656-4663
[9.]
J.C. Yao, C. Lombard-Bohas, E. Baudin, L.K. Kvols, P. Rougier, P. Ruszniewski, et al.
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.
J Clin Oncol, 28 (2010), pp. 69-676
[10.]
K.Y. Bilimoria, M.S. Talamonti, J.S. Tomlinson, A.K. Stewart, D.P. Winchester, C.Y. Ko, et al.
Pronostic score predicting suvival after resection of pancreatic neuroendocrine tumors.
Ann Surg, 247 (2008), pp. 490-500
Copyright © 2011. Sociedad Española de Endocrinología y Nutrición
